Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6944 matches for

Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20 million in Series A financing.

Flu vaccination on a woman

Similar stories

Oxford part of new international Pioneer Centre for medical data research

The University of Oxford has joined forces with Aarhus University and the University of Copenhagen to create a new Pioneer Centre that will become a significant international partner for data-driven medical research. The Pioneer Centre is anchored at Aarhus University with hub sites at each of the three universities and with a total grant of DKK 250 million.

Tech transfer partnership between universities creates company to transform care for millions of women

New Oxford quantum hub to tackle key challenges in quantum technologies

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine

Oxford spinout Brainomix is revolutionising stroke care through AI